Claravis (isotretinoin recalls
The FDA has published 1 recall involving Claravis (isotretinoin since 2016. The latest was reported on 12 Oct 2016. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 12 Oct 2016
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 1 100%
Why claravis (isotretinoin is recalled
Companies
By year
All claravis (isotretinoin recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Claravis (isotretinoin capsules USP), 10mg recalled | Teva North America | Potency & Assay | Nationwide |
Should you stop taking Claravis (isotretinoin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.